In this section

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomise

Sever, P. et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomise. Lancet, 361, pp. 1149-1158.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Gordon
Authors: Sever, P., Dahlof, B., Poulter, N., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S., Kristinsson, A., McInnes, G., Mehlsen, J., Nieminen, M., OBrien, E., Ostergren, J., and ASCOT Investigators,
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Lancet

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details